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Objectives: to determine the overall cardiovascular risk for patients with combined cardiac and carotid artery disease
undergoing synchronous coronary artery bypass (CABG) and carotid endarterectomy (CEA), staged CEA then CABG and
reverse staged CABG then CEA.
Design: systematic review of 97 published studies following 8972 staged or synchronous operations.
Results: mortality was highest in patients undergoing synchronous CEACABG (4.6%, 95% CI 4.1±5.2). Reverse
staged procedures (CABGÿCEA) were associated with the highest risk of ipsilateral stroke (5.8%, 95% CI 0.0±14.3) and
any stroke (6.3%, 95% CI 1.0±11.7). Peri-operative myocardial infarction (MI) was lowest following the reverse staged
procedure (0.9%, 95% CI 0.5±1.4) and highest in patients undergoing staged CEAÿCABG (6.5%, 95% CI 3.2±9.7).
The risk of death+ any stroke was highest in patients undergoing synchronous CEACABG (8.7%, 95% CI 7.7±9.8) and
lowest following staged CEAÿCABG (6.1%, 95% CI 2.9±9.3). The risk of death/stroke or MI was 11.5% (95% CI
10.1±12.9) following synchronous procedures versus 10.2% (95% CI 7.4±13.1) after staged CEA then CABG.
Conclusions: 10±12% of patients undergoing staged or synchronous procedures suffered death or major cardiovascular
morbidity (stroke, MI) within 30 days of surgery. Overall, there was no significant difference in outcomes for staged and
synchronous procedures and no comparable data for patients with combined cardiac and carotid disease not undergoing
staged or synchronous surgery.
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Introduction
A recent systematic review observed that the risk of
stroke after coronary artery bypass grafting (CABG)
was52% in patients with no significant carotid disease
(bilateral 0±49% stenoses), 3% in predominantly
asymptomatic patients with unilateral 50±99%
stenoses, increasing to 5% in those with bilateral
50±99% stenoses and 7±11% in patients with carotid
occlusion.1 However, it was not possible to determine
whether the risk of death+ stroke+MI (i.e. the over-
all cardiovascular risk) was significantly increased in
patients with combined carotid and cardiac disease
undergoing isolated CABG, especially in those
with more severe degrees of stenosis (80±99%). This
informationwas rarely (if ever) systematicallyreported.
More importantly, none of these data are available for
patients with 70±99 or 80±99% stenoses. If, however,
the cardiovascular risk were shown to be very high, it
would support the stance adopted by surgeons advo-
cating a more proactive surgical approach regarding
staged or synchronous interventions.
The current study is a systematic review of outcomes
following staged or synchronous procedures in 97
studies (8972 procedures) between 1972 and 2002.2±98
Only one contained any element of randomisation.34
The impetus for undertaking the study was the pub-
lication of a one-year community based prospective
audit following 236 synchronous CEACABGs from
10 states in the United States of America between 1995
and 1996 that reported a 17.4% risk of death/stroke at
30 days.90 If this does reflect current practice around
the world, then the overall cardiovascular risk in
patients with cardiac and carotid disease undergoing
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CABG alone would have to be extremely high to
justify any staged or synchronous interventions at all.
Materials and Methods
A systematic literature review was undertaken to
determine outcomes following (i) staged
(CEAÿCABG), (ii) reverse staged (CABGÿCEA)
and (iii) combined/synchronous (CEACABG).
Studies were identified by manual journal reviews
(European Journal of Vascular and Endovascular Surgery,
Journal of Vascular Surgery, Annals of Vascular Surgery,
Stroke, Annals of Thoracic Surgery, Journal of Thoracic and
Cardiothoracic Surgery), cross-referencing and an elec-
tronic PUBMED search using the advanced search
option. A number of combinations of search terms
were used that included one of `` carotid endarterect-
omy'', `` carotid surgery'', `` coronary surgery'', or
`` bypass surgery'' in combination with one of `` stroke'',
carotid or `` cardiac'' as appropriate.
Studies were included if published in English
language journals between January 1972 and June
2002 inclusive. Patients undergoing cardiac valvular
reconstructions or carotid reconstructions other than
endarterectomy (e.g. aorto-carotid bypass) were
excluded. One hundred and twelve series were iden-
tified for inclusion.2±113 Fifteen were subsequently
excluded.99±113 Reasons for exclusion included;
inability to secure a copy of the manuscript,99 nine
studies were updated from the same centre at a later
date,100±108 while in four it was not possible to differ-
entiate outcomes for staged and synchronous proce-
dures.109±112 The remaining study113 was excluded
because it included fewer patients than a similar series
from the same centre published one year earlier.62
Ninety-seven studies2±98 describing the outcome fol-
lowing 8972 staged or synchronous procedures were
included in the systematic review. Each was scru-
tinised to provide demographic and outcome data.
Demographic data included; (i) pre-operative neuro-
logical status (asymptomatic or symptomatic carotid
disease (irrespective of timing to the staged or syn-
chronous procedure), (ii) the presence of unilateral or
bilateral carotid disease, (iii) whether the CABG was
performed `` urgently'' e.g. for unstable angina, (iv) the
prevalence of left mainstem coronary artery disease
and (v) the proportion of patients deemed to be NYHA
class III or IV for cardiac disease.
Peri-operative events included any specified end-
point occurring 530 days of synchronous CEA
CABG or within 30 days of the latter of any staged
procedure. Endpoints included; (i) death, (ii) any
stroke, (iii) ipsilateral stroke appropriate to the side
of the CEA and (iv), myocardial infarction. It should
be noted, however, that there was no systematic
means of diagnosing peri-operative myocardial infarc-
tion over the 30-year period of this review (serial ECG
and/or enzyme changes) and many studies did not
document this outcome. Most were probably diag-
nosed following acute clinical deterioration. Accord-
ingly, the true incidence of peri-operative myocardial
infarction will be much higher. Most studies docu-
mented events occurring 530 days of surgery. Others
only recorded `` in-hospital'' events. For the purpose of
this review, the two have been combined as peri-
operative events. It is accepted that this may under-
represent the true risk, but this currently cannot be
avoided.
Previous publications and systematic reviews have
tended to document the prevalence of mortality, stroke
and myocardial infarction (MI) as discrete end-
points.114 However, this does not necessarily reflect the
fact that patients undergoing staged or synchronous
procedures may suffer more than one cardiovascular
event during the peri-operative period. Accordingly, it
has been difficult to gauge the overall cardiovascular
risk (operative death strokeMI).
Data have therefore been presented in an alternative
format so that the following end-points are clearly
documented where possible; (1) mortality, (2) any
stroke, (3) ipsilateral stroke, (4) myocardial infarction,
(5) death ipsilateral stroke, (6) death any stroke
and (7) death any strokeMI. Not all papers
reported this information and hence the denominator
may not be the same as the total number of patients in
the meta-analysis. In order to aid data interpretation,
the actual numbers of patients at risk for each of the
subgroups has been documented in the tables.
A statistician (RC) performed all analyses. Out-
comes have been analysed in two ways. In the first,
specific outcomes following each of the three proce-
dures were estimated by combining all the studies
that reported data on that particular outcome. Hetero-
geneity and 95% confidence intervals were deter-
mined (see below), but no direct statistical
comparisons were made.
In order to compare the risk of any given outcome
between staged and synchronous procedures directly,
the second method of analysis identified publications
reporting results for both staged and synchronous
procedures in a manner similar to Borger.115 Mantel-
Haenzal estimates of the Odds Ratio116 were then
determined along with measurements of hetero-
geneity and 95% confidence intervals. In the latter
analysis, confidence intervals for the odds ratio
were determined using Miettinen's test based
formula.117
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In those analyses where there was significant
heterogeneity, 95% confidence limits were expanded
to account for extra-binomial variation arising from
the differences in risk between studies.118 The hetero-
geneity of the actual risk and/or the odds ratio was
assessed by calculating the weighted sum of squared
deviations from the estimate. This statistic was then
compared to a chi-squared distribution to produce the
p-values listed in the tables and results.119 Measure-
ment of heterogeneity enables the reader to gauge
whether the pooled/calculated risks were measuring
the same thing. Statistically significant heterogeneity
(p5 0.05) in estimates between studies indicates that
the overall variation in the reported risk is greater
than would be expected by chance. This could be
due to differences in case-mix, operative technique
or other factors.
Results
Overview of all published series
Table 1 summarises the available demographic data
for 7863 patients undergoing synchronous CEA
CABG (94 studies) and 917 patients undergoing
staged CEAÿCABG (24 studies). Although 302
patients underwent reverse staged CABGÿCEA
(11 studies), there was often insufficient data to mean-
ingfully interpret patient demographics. Overall, about
60% of patients undergoing staged/synchronous
procedures were neurologically asymptomatic, while
30±37% had bilateral 50±99% stenoses or contralateral
occlusion. The majority of synchronous cases (72%)
were NYHA grade 3 or 4 (cardiac disease resulting in
marked limitation of physical activity (grade 3) or
cardiac disease resulting in inability to carry out
physical activity without discomfort (grade 4)), 39%
of synchronous cases were classed as `` urgent'' and left
mainstem disease was present in about 25% of patients.
Table 2 details the principal outcomes following
each procedure. Operative mortality was highest in
patients undergoing synchronous CEACABG
(4.6%, 95% CI 4.1±5.2). Reverse staged procedures
(CABGÿCEA) were associated with the highest risk
of both ipsilateral stroke (5.8%, 95% CI 0.0±14.3) and
any stroke (6.3%, 95% CI 1.0±11.7). The risk of `` any
operative stroke'' was lowest following staged
CEAÿCABG (2.7%, 95% CI 1.6±3.9). The risk of myo-
cardial infarction was lowest following reverse staged
procedures (0.9%, 95% CI 0.5±1.4) and highest in
patients undergoing staged CEAÿCABG (6.5%, 95%
CI 2.9±10). Note, however, that for each surgical
strategy, the 95% confidence intervals for all end-
points overlapped and that there was significant
heterogeneity in virtually every endpoint.
Table 2 also details the cumulative cardiovascular
risk following the three types of intervention. Death
any stroke was highest in patients undergoing syn-
chronous CEACABG (8.7%, 95% CI 7.7±9.8) and
lowest following staged CEAÿCABG (6.1%, 95% CI
2.4±9.2), although the confidence intervals over-
lapped. However, the apparent benefit conferred by
staging the operation was reduced when the risk of
myocardial infarction was subsequently included
in the analysis (synchronous 11.5% (95% CI 10.1±
12.9), staged CEAÿCABG 10.2% (95% CI 7.4±13.1).
Note, however, that the p-value indicative of
heterogeneity was 50.05 for almost every parameter
Table 1. Demography on patients undergoing staged or synchronous CEACABG.
Synchronous CEACABG Staged CEAÿCABG Staged CABGÿCEA
Number of studies 94 24 11
Total number of patients 7863 917 302
Symptomatic carotid stenosis  2830/6827 266/611 33/71
41.1% (95% CI 37.4±44.9) 43.5% (95% CI 31.1±56.0) 46.5% (13.9±79.1)
Asymptomatic carotid stenosis  4048/6878 351/611 38/62
59.3% (95% CI 55.6±63.0) 57.4% (95% CI 44.4±70.5) 61.3% (29.0±99.6)
Unilateral 50±99% stenosis  3826/6137 396/570 Insufficient data
62.3% (95% CI 58.6±66.1) 69.5% (95% CI 59.6±79.4)
Bilateral 50±99% stenosis/occlusion  2261/6137 186/570 Insufficient data
36.8% (95% CI 32.9±40.8) 30.5% (95% CI 22.2±43.1)
`` Urgent'' CABG  1675/4287 50/173 45/79
39.1% (95% CI 33.9±44.2) 28.9 (95% CI 9.4±48.4) 59% (24.0±90.0)
Left mainstem disease 1240/5017 137/499 Insufficient data
24.7% (95% CI 21.5±27.9) 27.5% (95% CI 9.9±45.0)
NYHA grade 3 or 4  885/1231 Insufficient data Insufficient data
71.9% (95% CI 65.1±78.7)
 Some papers did not provide all of this information and hence the denominator will not be the same as the total number of patients in the
meta-analysis.
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under analysis. This indicates that there was no sys-
tematic similarity in the reporting of events between
studies.
The available evidence therefore suggests that 10±
12% of patients undergoing staged or synchronous
procedures suffer death or a major non-fatal cardio-
vascular event in the peri-operative period. However,
the extent of risk varied across studies (0±30%) with
seven out of 32 series documenting outcome in 450
patients reporting a 415% risk of death/stroke/MI.
Only five studies (containing 50 patients) have
reported the overall cardiovascular risk following
staged CEAÿCABG and they also reported a similar
spread of risk to that observed with synchronous pro-
cedures. The risk of death+ any stroke+MI in the
five studies was 5.8,76 8.2,63 10.7,62 13.098 and 16.9%.8
Only one study with 50 patients10 documented the
overall cardiovascular risk following staged CABG
then CEA (4.8%).
Comparison with previous meta-analyses
Table 3 summarises the principal findings from the
1992 meta-analysis by Brener,114 which was based on
observations from 35 studies (2928 patients). When
compared with the same data from the 2002 syste-
matic review (Table 3), several important trends have
emerged.
Firstly, all discrete risks (mortality, stroke, MI) have
decreased. Outcomes following synchronous proce-
dures have improved by 1±2% across all end-points.
Operative mortality following staged CEAÿCABG
has fallen from 9.4 to 3.9%, largely because the
mortality following 630 staged CEAÿCABG proce-
dures published in 10 series between 1992 and 2002
was only 3.3%.49,52,55,62,63,69,72,76,82,98 The same studies
documented a 2.4% operative stroke rate that undoub-
tedly contributed towards the fall in overall stroke rate
from 5.3 (1972±1992) to 2.7% (1972±2002). A similar
trend was observed for declining risks of myocardial
infarction.
There have been only 11 published studies (302
patients) documenting outcome following staged
CABGÿCEA over the last 30 years. Since the 1992
overview, only three `` new'' studies have been pub-
lished56,62,71 adding 71 patients to the available litera-
ture. These three studies, however, documented a zero
percent mortality, a 1.4% stroke rate and a 1.4% risk of
MI. Overall; the cardiovascular risk (death/stroke/
MI) in these three studies was 2.8%. The latter results
have contributed significantly to the improvement in
outcomes following staged CABGÿCEA when com-
pared to the 1992 meta-analysis (Table 3).
Table 3. Comparison of results from 1992 meta-analysis of patients
undergoing staged or synchronous CEACABG  with current
systematic review.
Procedure Studies Patients Stroke (%) MI (%) Death (%)
Synchronous CEACABG
1992 35 2308 6.2 4.7 5.6
2002 94 7753 4.6 3.6 4.6
Staged CEA then CABG
1992 15 407 5.3 11.5 9.4
2002 23 917 2.7 6.5 3.9
Staged CABG then CEA
1992 6 213 10.0 2.7 3.6
2002 11 302 6.3 0.9 2.0
Adapted from Brener et al.114
Table 2. Peri-operative outcomes for synchronous and staged CEAÿCABG. 
Operative
mortality
Ipsilateral
stroke
Any
stroke
Myocardial
infarction
Death
Ipsilat CVA
Death
any CVA
Death
any CVAMI
Synchronous CEACABG
Observed risk 359/7753 167/5643 333/7206 173/4800 413/5563 635/7260 513/4463
Risk % 4.6 3.0 4.6 3.6 7.4 8.7 11.5
95% CI 4.1±5.2 2.4±3.5 3.9±5.4 3.0±4.2 6.5±8.3 7.7±9.8 10.1±12.9
Heterogeneity (p) 0.0048 0.0002 50.0001 0.0174 0.0001 50.0001 50.000
Staged CEAÿCABG
Observed risk 36/917 20/809 25/917 53/817 39/809 56/917 72/709
Risk % 3.9 2.5 2.7 6.5 4.8 6.1 10.2
(95% CI) 1.1±6.7 1.3±3.6 1.6±3.9 3.2±9.7 2.8±6.8 2.9±9.3 7.4±13.1
Heterogeneity (p) 50.0001 50.0001 50.0001 0.9968 50.0001 50.0001 50.0001
Staged CABGÿCEA
Observed risk 6/302 5/87 19/302 2/221 3/87 22/302 11/221
Risk % 2.0 5.8 6.3 0.9 3.4 7.3 5.0
(95% CI) 0.0±6.1 0.0±14.3 1.0±11.7 0.5±1.4 0.0±9.80 1.7±12.9 0.0±10.6
Heterogeneity 50.0001 0.2190 0.1784 50.0001 0.0060 50.0001 0.0102
 Some papers did not provide all of this information and hence the denominator will not be the same as the total number of patients in the
meta-analysis.
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Studies publishing outcomes on both staged and
combined procedures
An alternative method of presenting comparative data
(allowing for some element of statistical comparison)
is to specifically analyse only those studies reporting
results for both staged (either CABGÿCEA or
CEAÿCABG) and synchronous procedures. In 1999,
Borger115 performed this type of analysis based upon
16 studies (1764 patients) published between 1972 and
1998. Outcomes for staged CEAÿCABG were com-
bined with those for staged CABGÿCEA and then
compared with synchronous procedures (Table 4).
Although, synchronous procedures were associated
with a systematically worse outcome than staged
operations, none of the differences reached statistical
significance.
The current review undertook a similar analysis
having identified a total of 24 studies (2284 patients)
from the literature. Table 5 summarises the absolute
risks, 95% CIs, heterogeneity and Odds Ratios. Note
that the absolute risks will inevitably be slightly dif-
ferent to those presented in Table 2.
Staged procedures were associated with a lower
absolute risk than synchronous operations for all end-
points with the exception of myocardial infarction.
The confidence intervals overlapped and only death-
 ipsilateral stroke was associated with an Odds Ratio
and 95% CIs 41 (1.57 (95% CI 1.05±2.35)). However, it
is important to note that the p values for heterogeneity
were consistently 40.05. The lack of significant het-
erogeneity in estimates between studies indicates that
the overall variation in the reported odds ratios is
compatible with that expected by chance alone. This
consistency suggests that the estimates are likely to be
both reliable and generalisable.
Discussion
There has been much controversy regarding the opti-
mum management of patients with combined cardiac
and coronary artery disease. To-date, no level I evidence
exists to guide practice. In reality, however, most
carotid patients will have varying degrees of ischaemic
heart disease (and vice versa), but the vast majority
can safely undergo surgery (CEA or CABG) with the
choice reflecting the clinical priority. In practice, there-
fore, only a relatively small minority of patients require
the clinician to even consider a staged or synchronous
reconstruction.
In this era of evidence-based medicine, it seems
ironic that a multi-centre randomised trial could easily
address this issue. In practice, however, the planning
and implementation of such a trial has been beset with
many practical, theoretical and logistical problems
Table 4. Summary of Borger's meta-analysis of 16 studies (1764
patients) reporting outcomes where both staged  and synchro-
nous procedures were reported. y
Procedure Patients Stroke Death Stroke/
death
Synchronous procedure 844 6.0% 4.7% 9.5%
Any staged procedure 920 3.2% 2.9% 5.7%
Odds ratio (95% CI) for
synchronous versus
staged procedures z
1.50
(0.97±2.32)
1.55
(0.94±2.53)
1.49
(1.03±2.15)
Outcomes for staged CEAÿCABG added to those with staged
CABGÿCEA and compared with synchronous outcomes from
same paper.
yAdapted from Borger et al.115
zOdds Ratio of hazard occurring as a function of synchronous
versus staged procedures. If the OR is 41.0 this indicates that the
risk is more commonly associated with synchronous procedures
(and vice versa). For the Odds Ratio to be statistically significant,
both 95% CIs must be either 41.0 or 51.0.
Table 5. Risk/hazard ratio of suffering an adverse event during staged or synchronous operations: both procedures reported in the same
paper. 
30 day parameter Observed risk % risk (95% CIs) 95% CIs p-value
Synchronous Staged Synchronous Staged
Odds Ratio y Heterogeneity
Operative death 57/1171 40/1113 4.9 (3.7±6.1) 3.7 (1.7±5.7) 1.28 (0.80±2.05) 0.9134
Any stroke 62/1171 40/1113 5.4 (3.4±7.2) 3.7 (1.8±5.5) 1.28 (0.82±2.00) 0.7017
Ipsilateral stroke 37/941 20/766 3.9 (2.4±5.4) 2.7 (0.8±4.7) 1.33 (0.71±2.48) 0.9616
Myocardial infarction 42/971 50/958 4.3 (2.9±5.8) 5.3 (3.4±7.2) 0.68 (0.42±1.10) 0.9822
Death/ipsilat stroke 78/941 36/766 8.3 (6.2±10.5) 4.8 (2.2±7.3) 1.57 (1.03±2.39) 0.4355
Death/any stroke 111/1171 73/1113 9.5 (7.2±11.8) 6.6 (4.4±8.8) 1.34 (0.96±1.87) 0.2689
Death/stroke/MI 105/920 81/869 11.5 (8.9±14.0) 9.4 (6.4±12.4) 1.09 (0.75±1.59) 0.2701
Outcomes for staged CEAÿCABG were added to staged CABGÿCEA and reported as `` staged'' and then compared with synchronous
outcomes from the same paper.
yOdds Ratio of hazard occurring as a function of synchronous versus staged procedures. If the OR is41.0 this indicates that the risk is more
commonly associated with synchronous procedures (and vice versa). For the Odds Ratio to be statistically significant, both 95% CIs must be
either 41.0 or 51.0.
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including; (i) is the principle reason for considering
staged/synchronous surgery the prevention of opera-
tive stroke, long term stroke or both, (ii) relatively little
emphasis is placed on preventing peri-operative myo-
cardial infarction, (iii) there are a number of different
patient populations under consideration and manage-
ment strategies will inevitably be influenced by the
dominant pathology. The symptomatic carotid patient
with unstable angina is a completely different prob-
lem to the elective CABG patient with a unilateral
asymptomatic carotid stenosis, who is in turn, a better
prospect than urgent CABG in a patient with a
recently symptomatic carotid stenosis, (iv) what is
really meant by `` staging''? In many studies, staging
has included operations separated by up to six months
(hardly comparable to a synchronous operation) and
(iv), the potential role for carotid angioplasty in the
future.
In the absence of randomised trial data, what is the
available evidence regarding (i) the risk of stroke in
CABG patients with carotid disease, (ii) the role of
carotid artery disease in post-CABG stroke, (iii) the
cumulative cardiovascular risk in patients with carotid
disease undergoing CABG, (iv) whether staged or
synchronous surgery can reduce this risk and (v) evi-
dence that either staged or synchronous procedures
are preferable?
It is difficult to ascertain the true risk of stroke in
patients undergoing CABG with carotid disease. This
is primarily because most centres performing pre-
operative duplex screening tend to advocate staged
CEAÿCABG or synchronous CEACABG in pati-
ents with severe carotid disease. In a recent systematic
review (1), three studies documented the risk of
carotid disease and the ensuing stroke risk in 4674
patients undergoing CABG. Approximately, 91% of
screened patients (who would have been predomin-
antly neurologically asymptomatic) had no significant
carotid disease (550% stenoses bilaterally) and
incurred an operative stroke risk of 1.8% (95% CI
1.4±2.1) (1). Unilateral 50±99% stenoses were detected
in 5.5% of patients (stroke risk 3.2%, 95% CI 0.0±6.5),
bilateral 50±99% stenoses affected 2.2% (5.2% stroke
risk, 95% CI 0.0±10.8), while only 1.5% of CABG
patients had unilateral or bilateral carotid occlusions
(incurring the highest operative stroke risk of 7±12%,
95% CI 0.0±20). There were insufficient data to perform
a similar meta-analysis for patients with 480%
carotid stenoses (few trials, even fewer patients not
subjected to prophylactic CEA, stroke data seldom sub-
grouped for unilateral, bilateral stenoses or occlusion).
This is unfortunate as patients with more severe
carotid disease (e.g. 80±99% stenoses, bilateral ste-
noses/occlusions) may be at particular risk during
CABG and could obtain the greatest benefit from
staged or synchronous interventions. Accordingly,
the evidence for planning management strategies cur-
rently has to be based on data derived from patients
with 50±99% stenoses, despite the fact that few sur-
geons would actually advocate staged or synchronous
CEA in patients with 50±70% stenoses.
The second issue relates to whether carotid disease
is the predominant cause of post-CABG stroke.
The systematic review (1) observed that significant
`` carotid'' predictors included; (i) carotid bruit (Odds
Ratio 3.6 (95% CI 2.8±4.6), (ii) prior stroke/TIA (Odds
Ratio 3.6 (95% CI 2.7±4.9) and (iii) a severe carotid
stenosis or occlusion (Odds Ratio 4.3 (95% CI 3.2±
5.7). However, a number of observations suggested
that the majority of post-CABG strokes could not,
simply, be attributed to carotid disease alone (1).
These included; (i) 62% of operative strokes occurred
after 424 h had elapsed, i.e., they could not simply be
attributed to intra-operative haemodynamic failure
(ii) 50% of stroke sufferers in the overview did not
have significant ipsilateral carotid artery disease
(450% stenosis or occlusion) and (iii) up to 60% of
territorial infarctions on CT/autopsy were not ipsilat-
eral to significant carotid disease (450% stenosis or
occlusion) (1). Thus, although the available evidence
suggests that carotid disease is an important aetio-
logical factor in post-CABG stroke, it is probably
only responsible for about 50% of post-CABG strokes.
There is now a prevailing view that aortic arch athero-
embolism is the single most important cause of post-
CABG stroke. Interestingly, carotid bruit is the only
clinical predictor for significant aortic arch disease120
and the combination of aortic arch disease and carotid
stenosis in CABG patients has been associated with a
14% operative stroke risk.121
The third issue relates to cumulative cardiovascular
risk. To-date, most publications have concentrated on
reporting discrete variables (death, stroke or MI) in
patients undergoing isolated, staged or synchronous
CABG. Surprisingly, little is known about whether the
cardiovascular risk (death/stroke or death/stroke/
MI) is significantly increased in patients with carotid
and cardiac disease. Most clinicians, intuitively, view
the presence of asymptomatic, severe carotid disease
in CABG patients as being a marker of generalised
atherosclerotic disease and of increased cardiovascu-
lar risk. Interestingly, the converse does not appear to
hold true. This is a key issue to resolve as the concept
of planning isolated, staged or synchronous opera-
tions is ultimately based on the premise that all
major risks should be reduced rather than discrete
reductions in individual end-points. In short, the
rationale underlying staged CEAÿCABG or
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synchronous CEACABG is not simply to reduce
operative stroke. It should be to minimise the risk of
death, stroke and MI.
In one of the few studies of its kind, Das observed
that the risk of death and/or stroke in patients with
severe carotid stenoses undergoing CABG alone could
be as high as 11.5%.122 This therefore suggests that
combined carotid and cardiac disease does confer
excess cardiovascular risk. However, no systematic
review, to-date, has documented the overall cardio-
vascular risk (death/stroke/MI) in CABG patients
with carotid disease undergoing isolated CABG. If
one assumes that Das' data are correct, the overall
cardiovascular risk might be as high as 12±15%.
The current systematic review has addressed the
two remaining issues relating to the role of staged
and synchronous procedures in patients with com-
bined carotid and cardiac disease. Tables 2 and 5 indi-
cate that staged and synchronous interventions were
associated with a 7±10% risk of death and/or stroke
and a 10±12% risk of death/stroke or MI. Although
not a randomised comparison, the available data sug-
gests that staged/synchronous operations might be
able to reduce the death stroke rate from the 11.5%
risk observed in isolated CABG procedures. It remains
uncertain, however, as to whether either strategy
could ever confer a clinically significant reduction.
Clearly, more information is required regarding age,
unilateral/bilateral nature of carotid artery disease,
increasing disease severity and whether the patient
was neurologically symptomatic or not. Moreover,
the risks of operative MI must also be considered. In
the current overview, staged procedures were asso-
ciated with a 9.4% risk of death/stroke/MI as com-
pared with synchronous operations (11.5%). We still
do not know how this compares with the risk observed
in patients undergoing isolated CABG in the presence
of significant carotid artery disease.
Finally, if one assumes that staged or synchronous
surgery might confer some benefit, is there any evi-
dence that either strategy is preferable? The data from
Tables 2 and 5 suggest that although staged proce-
dures were generally associated with a lower overall
complication rate than synchronous ones, none of the
comparisons reached statistical significance. The lack
of heterogeneity suggests that this was a consistent
finding across most of the constituent studies.
Accordingly, there is no systematic evidence that,
when faced with the same type of patient, one strategy
is preferable to the other. It remains debatable as to
whether the patient groups included in the overall
and paired analyses were really comparable, as most
surgeons will inevitably exercise some form of prefer-
ence and prioritisation depending upon the urgency
of presentation. In particular, one should be aware of
the potential for introducing bias when interpreting
the results of staged procedures. One of the largest
series reporting both synchronous (n 255) and
staged (n 257) procedures (data included in Table 5)
observed that unstable and/or urgent cases tended to
undergo synchronous operations, while staged inter-
ventions were reserved for less severe cases.63 This is
to be expected, but must be taken into account when
interpreting the findings in Table 5. Secondly, there is
the potential for `` non-reporting'' of major adverse
events (death, stroke, MI) following the primary pro-
cedure that were sufficiently severe to abandon plans
for the second staged procedure. An indeterminate
number of studies (largely retrospective) did not
specify whether adverse events occurring after the
first operation (thereby precluding performance of
the second) were always included in the overall
results on an `` intention to treat basis'' or were they
censored and the patient excluded on the basis that
they did not undergo a staged double procedure.
Finally, the definition of `` staging'' must be clarified.
At present it seems to include any combination of CEA
or CABG within a six-month period of each other.
In conclusion, this systematic review has observed
that staged and synchronous procedures were asso-
ciated with a 7±9% risk of death/stroke and a 10±12%
risk of death/stroke or MI in the peri-operative per-
iod. Until parallel data are available for similar pati-
ents undergoing isolated CABG, it remains unclear
whether staged or synchronous procedures confer any
overall benefit. In the absence of randomised trial
data, future publications must clearly discriminate
between patient subgroups, e.g., the highly symptom-
atic carotid patient with unstable cardiac disease as
compared with the elective CABG patient with asymp-
tomatic carotid disease. Second, centres with data
documenting the risk of death/stroke and MI in
CABG patients with 70±99 and 80±99% stenoses who
do not undergo staged or synchronous CEA are urged
to submit their results for publication.
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